NFLX Netflix | $973.03
+1.2% | 4/18/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $1,150.00 | N/A | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 4/18/2025 |
MRK Merck & Co., Inc. | $77.93
+1.9% | 4/17/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $115.00 -> $115.00 | Low | View details for Guggenheim rating of Merck & Co., Inc. (NYSE:MRK) on 4/17/2025 |
GEV GE Vernova | $322.81
-1.6% | 4/17/2025 | Reiterated by | Guggenheim | Analyst J. Osha | Buy -> Buy | $380.00 -> $380.00 | Low | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 4/17/2025 |
ITRI Itron | $103.26
+1.6% | 4/17/2025 | Reiterated by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $133.00 -> $133.00 | Low | View details for Guggenheim rating of Itron (NASDAQ:ITRI) on 4/17/2025 |
ABBV AbbVie | $172.78
+0.6% | 4/17/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $214.00 -> $214.00 | Low | View details for Guggenheim rating of AbbVie (NYSE:ABBV) on 4/17/2025 |
NOW ServiceNow | $772.18
-3.1% | 4/16/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Sell -> Sell | $716.00 -> $716.00 | High | View details for Guggenheim rating of ServiceNow (NYSE:NOW) on 4/16/2025 |
CYRX Cryoport | $5.55
-1.1% | 4/16/2025 | Reiterated by | Guggenheim | Analyst S. Nambi | Buy -> Buy | $10.00 -> $10.00 | Medium | View details for Guggenheim rating of Cryoport (NASDAQ:CYRX) on 4/16/2025 |
ONC Beigene | $230.98
+1.2% | 4/16/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | | Medium | View details for Guggenheim rating of Beigene (NASDAQ:ONC) on 4/16/2025 |
VERV Verve Therapeutics | $4.59
+1.8% | 4/15/2025 | Target Raised by | Guggenheim | Analyst Etzer Darout | Buy -> Buy | $18.00 -> $24.00 | High | View details for Guggenheim rating of Verve Therapeutics (NASDAQ:VERV) on 4/15/2025 |
FLNC Fluence Energy | $3.69
+1.4% | 4/15/2025 | Target Lowered by | Guggenheim | Analyst J. Osha | Sell -> Sell | $6.00 -> $2.00 | High | View details for Guggenheim rating of Fluence Energy (NASDAQ:FLNC) on 4/15/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
LLY Eli Lilly and Company | $841.70
+14.5% | 4/14/2025 | Target Lowered by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | $973.00 -> $928.00 | Low | View details for Guggenheim rating of Eli Lilly and Company (NYSE:LLY) on 4/14/2025 |
PLNT Planet Fitness | $93.91
-0.6% | 4/14/2025 | Target Raised by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $105.00 -> $110.00 | Low | View details for Guggenheim rating of Planet Fitness (NYSE:PLNT) on 4/14/2025 |
USFD US Foods | $62.24
+1.1% | 4/14/2025 | Reiterated by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $80.00 -> $80.00 | Low | View details for Guggenheim rating of US Foods (NYSE:USFD) on 4/14/2025 |
TVTX Travere Therapeutics | $14.92
+2.4% | 4/14/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $47.00 -> $47.00 | Low | View details for Guggenheim rating of Travere Therapeutics (NASDAQ:TVTX) on 4/14/2025 |
EXAS Exact Sciences | $41.58
-1.6% | 4/11/2025 | Reiterated by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $60.00 -> $60.00 | High | View details for Guggenheim rating of Exact Sciences (NASDAQ:EXAS) on 4/11/2025 |
TGNA TEGNA | $16.08
+2.0% | 4/11/2025 | Target Lowered by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $22.00 -> $20.00 | Low | View details for Guggenheim rating of TEGNA (NYSE:TGNA) on 4/11/2025 |
ANIP ANI Pharmaceuticals | $69.21
+0.0% | 4/11/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $86.00 -> $86.00 | High | View details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 4/11/2025 |
ONC Beigene | $230.98
+1.2% | 4/10/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $348.00 -> $348.00 | High | View details for Guggenheim rating of Beigene (NASDAQ:ONC) on 4/10/2025 |
PRIM Primoris Services | $56.35
-2.4% | 4/10/2025 | Reiterated by | Guggenheim | Analyst J. Osha | Buy -> Buy | $110.00 -> $110.00 | Low | View details for Guggenheim rating of Primoris Services (NASDAQ:PRIM) on 4/10/2025 |
MBX MBX Biosciences | $7.62
+1.5% | 4/10/2025 | Reiterated by | Guggenheim | Analyst S. Fernandez | Buy -> Buy | $44.00 -> $44.00 | Medium | View details for Guggenheim rating of MBX Biosciences (NYSE:MBX) on 4/10/2025 |
DKNG DraftKings | $33.61
0.0% | 4/10/2025 | Target Lowered by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $62.00 -> $61.00 | Low | View details for Guggenheim rating of DraftKings (NASDAQ:DKNG) on 4/10/2025 |
NEOG Neogen | $4.39
-4.6% | 4/10/2025 | Target Lowered by | Guggenheim | Analyst S. Nambi | Buy -> Buy | $15.00 -> $13.00 | High | View details for Guggenheim rating of Neogen (NASDAQ:NEOG) on 4/10/2025 |
ACHC Acadia Healthcare | $23.91
+0.3% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $36.00 | High | View details for Guggenheim rating of Acadia Healthcare (NASDAQ:ACHC) on 4/9/2025 |
CI The Cigna Group | $329.97
+0.2% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $384.00 | High | View details for Guggenheim rating of The Cigna Group (NYSE:CI) on 4/9/2025 |
HUM Humana | $264.41
-7.4% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $326.00 | High | View details for Guggenheim rating of Humana (NYSE:HUM) on 4/9/2025 |
HCA HCA Healthcare | $334.38
+1.0% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Neutral | | High | View details for Guggenheim rating of HCA Healthcare (NYSE:HCA) on 4/9/2025 |
CYH Community Health Systems | $2.41
-4.5% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Neutral | | High | View details for Guggenheim rating of Community Health Systems (NYSE:CYH) on 4/9/2025 |
UHS Universal Health Services | $174.57
+0.5% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $208.00 | High | View details for Guggenheim rating of Universal Health Services (NYSE:UHS) on 4/9/2025 |
THC Tenet Healthcare | $121.47
+0.9% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $165.00 | High | View details for Guggenheim rating of Tenet Healthcare (NYSE:THC) on 4/9/2025 |
MOH Molina Healthcare | $322.57
-3.0% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Neutral | | Medium | View details for Guggenheim rating of Molina Healthcare (NYSE:MOH) on 4/9/2025 |
CNC Centene | $60.70
-2.1% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Neutral | | Medium | View details for Guggenheim rating of Centene (NYSE:CNC) on 4/9/2025 |
ELV Elevance Health | $424.44
-2.4% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $518.00 | High | View details for Guggenheim rating of Elevance Health (NYSE:ELV) on 4/9/2025 |
VCYT Veracyte | $31.14
-1.2% | 4/9/2025 | Target Lowered by | Guggenheim | Analyst S. Nambi | Buy -> Buy | $45.00 -> $37.00 | High | View details for Guggenheim rating of Veracyte (NASDAQ:VCYT) on 4/9/2025 |
ARDT Ardent Health Partners | $12.50
+1.6% | 4/9/2025 | Initiated by | Guggenheim | Analyst Jason Cassorla | Buy | $16.00 | High | View details for Guggenheim rating of Ardent Health Partners (NYSE:ARDT) on 4/9/2025 |
MYGN Myriad Genetics | $7.64
-3.4% | 4/9/2025 | Downgraded by | Guggenheim | Analyst Subbu Nambi | Buy -> Neutral | | High | View details for Guggenheim rating of Myriad Genetics (NASDAQ:MYGN) on 4/9/2025 |
META Meta Platforms | $501.48
-0.2% | 4/8/2025 | Target Lowered by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $750.00 -> $675.00 | Medium | View details for Guggenheim rating of Meta Platforms (NASDAQ:META) on 4/8/2025 |
YUM Yum! Brands | $143.13
+0.4% | 4/8/2025 | Target Raised by | Guggenheim | Analyst Gregory Francfort | Buy -> Buy | $155.00 -> $165.00 | High | View details for Guggenheim rating of Yum! Brands (NYSE:YUM) on 4/8/2025 |
FE FirstEnergy | $41.87
+2.6% | 4/7/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $45.00 -> $47.00 | Low | View details for Guggenheim rating of FirstEnergy (NYSE:FE) on 4/7/2025 |
FSLR First Solar | $127.98
+2.9% | 4/7/2025 | Target Lowered by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $304.00 -> $253.00 | Medium | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 4/7/2025 |
IVA Inventiva | $3.36
+1.5% | 4/4/2025 | Target Lowered by | Guggenheim | Analyst Etzer Darout | Buy -> Buy | $12.00 -> $9.00 | High | View details for Guggenheim rating of Inventiva (NASDAQ:IVA) on 4/4/2025 |
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now (Ad) Did Elon Musk just set the stage for the next AI stock explosion?
One 30-year Wall Street veteran thinks so.
Musk has been quietly creating one of the most ambitious AI ventures in history. For all the details - including the name and ticker of our #1 AI stock to buy right now - click here |
QSR Restaurant Brands International | $63.23
+1.6% | 4/4/2025 | Target Raised by | Guggenheim | Analyst G. Francfort | Buy -> Buy | $71.00 -> $77.00 | High | View details for Guggenheim rating of Restaurant Brands International (NYSE:QSR) on 4/4/2025 |
NBTX Nanobiotix | $3.34
+1.8% | 4/4/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $12.00 -> $8.00 | Low | View details for Guggenheim rating of Nanobiotix (NASDAQ:NBTX) on 4/4/2025 |
IONS Ionis Pharmaceuticals | $28.40
+0.2% | 4/3/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | | High | View details for Guggenheim rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 4/3/2025 |
ARQT Arcutis Biotherapeutics | $13.01
+0.4% | 4/3/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | Medium | View details for Guggenheim rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 4/3/2025 |
RH RH | $160.42
+4.3% | 4/3/2025 | Target Lowered by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $500.00 -> $300.00 | High | View details for Guggenheim rating of RH (NYSE:RH) on 4/3/2025 |
KR Kroger | $71.30
+3.3% | 4/3/2025 | Target Raised by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $71.00 -> $73.00 | High | View details for Guggenheim rating of Kroger (NYSE:KR) on 4/3/2025 |
NFLX Netflix | $973.03
+1.2% | 4/3/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $1,100.00 -> $1,100.00 | Low | View details for Guggenheim rating of Netflix (NASDAQ:NFLX) on 4/3/2025 |
SRAD Sportradar Group | $23.96
+0.4% | 4/3/2025 | Reiterated by | Guggenheim | Analyst C. Baker | Buy -> Buy | $27.00 -> $27.00 | Low | View details for Guggenheim rating of Sportradar Group (NASDAQ:SRAD) on 4/3/2025 |
ORCL Oracle | $128.56
-0.9% | 4/3/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $220.00 -> $220.00 | Low | View details for Guggenheim rating of Oracle (NYSE:ORCL) on 4/3/2025 |
TWST Twist Bioscience | $36.80
-4.3% | 3/28/2025 | Target Set by | Guggenheim | - | | $50.00 | High | View details for Guggenheim rating of Twist Bioscience (NASDAQ:TWST) on 3/28/2025 |
CMPX Compass Therapeutics | $1.75
+2.9% | 4/2/2025 | Reiterated by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | $12.00 -> $12.00 | High | View details for Guggenheim rating of Compass Therapeutics (NASDAQ:CMPX) on 4/2/2025 |
MAZE Maze Therapeutics | $8.41
+2.8% | 4/2/2025 | Reiterated by | Guggenheim | Analyst D. Chattopadhyay | Buy -> Buy | $19.00 -> $19.00 | Medium | View details for Guggenheim rating of Maze Therapeutics (NASDAQ:MAZE) on 4/2/2025 |
SNAP Snap | $7.86
+1.6% | 4/2/2025 | Reiterated by | Guggenheim | Analyst M. Morris | Neutral -> Neutral | | Low | View details for Guggenheim rating of Snap (NYSE:SNAP) on 4/2/2025 |
PHAT Phathom Pharmaceuticals | $4.03
-4.5% | 4/2/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | | High | View details for Guggenheim rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 4/2/2025 |
JNJ Johnson & Johnson | $157.42
+2.3% | 4/2/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Neutral -> Neutral | | Low | View details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 4/2/2025 |
PINS Pinterest | $25.17
-1.1% | 4/1/2025 | Reiterated by | Guggenheim | Analyst M. Morris | Buy -> Buy | | Low | View details for Guggenheim rating of Pinterest (NYSE:PINS) on 4/1/2025 |
SR Spire | $77.48
-0.1% | 4/1/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Neutral -> Neutral | $67.00 -> $72.00 | Medium | View details for Guggenheim rating of Spire (NYSE:SR) on 4/1/2025 |
PRGS Progress Software | $56.00
-0.1% | 4/1/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $83.00 -> $83.00 | High | View details for Guggenheim rating of Progress Software (NASDAQ:PRGS) on 4/1/2025 |
PMN ProMIS Neurosciences | $0.64
+3.4% | 4/1/2025 | Reiterated by | Guggenheim | Analyst Eddie Hickman | Buy -> Buy | $6.00 -> $6.00 | High | View details for Guggenheim rating of ProMIS Neurosciences (NASDAQ:PMN) on 4/1/2025 |
CABA Cabaletta Bio | $1.10
+1.9% | 4/1/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $23.00 -> $23.00 | High | View details for Guggenheim rating of Cabaletta Bio (NASDAQ:CABA) on 4/1/2025 |
ADCT ADC Therapeutics | $1.22
+4.7% | 3/31/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $10.00 -> $7.00 | High | View details for Guggenheim rating of ADC Therapeutics (NYSE:ADCT) on 3/31/2025 |
BROS Dutch Bros | $58.26
+0.9% | 3/31/2025 | Target Raised by | Guggenheim | Analyst Gregory Francfort | Buy -> Buy | $54.00 -> $72.00 | Medium | View details for Guggenheim rating of Dutch Bros (NYSE:BROS) on 3/31/2025 |
DLTR Dollar Tree | $79.14
+8.1% | 3/28/2025 | Target Lowered by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $100.00 -> $95.00 | Medium | View details for Guggenheim rating of Dollar Tree (NASDAQ:DLTR) on 3/28/2025 |
MRUS Merus | $43.06
+2.7% | 3/28/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $109.00 -> $109.00 | Low | View details for Guggenheim rating of Merus (NASDAQ:MRUS) on 3/28/2025 |
IPSC Century Therapeutics | $0.54
+8.7% | 3/28/2025 | Reiterated by | Guggenheim | Analyst Kelsey Goodwin | Buy -> Buy | | High | View details for Guggenheim rating of Century Therapeutics (NASDAQ:IPSC) on 3/28/2025 |
SLNO Soleno Therapeutics | $69.98
+0.1% | 3/28/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | $70.00 -> $81.00 | High | View details for Guggenheim rating of Soleno Therapeutics (NASDAQ:SLNO) on 3/28/2025 |
CSTL Castle Biosciences | $21.51
+1.2% | 3/28/2025 | Target Set by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $30.00 | High | View details for Guggenheim rating of Castle Biosciences (NASDAQ:CSTL) on 3/28/2025 |
EXAS Exact Sciences | $41.58
-1.6% | 3/28/2025 | Target Set by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $60.00 | High | View details for Guggenheim rating of Exact Sciences (NASDAQ:EXAS) on 3/28/2025 |
CNTA Centessa Pharmaceuticals | $12.30
+4.0% | 3/26/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | $28.00 -> $28.00 | High | View details for Guggenheim rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 3/26/2025 |
RH RH | $160.42
+4.3% | 3/26/2025 | Target Lowered by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $550.00 -> $500.00 | Medium | View details for Guggenheim rating of RH (NYSE:RH) on 3/26/2025 |
IFRX InflaRx | $1.06
+1.0% | 3/26/2025 | Target Raised by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $7.00 -> $10.00 | High | View details for Guggenheim rating of InflaRx (NASDAQ:IFRX) on 3/26/2025 |
ADAP Adaptimmune Therapeutics | $0.24
-0.8% | 3/26/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $3.00 -> $1.75 | High | View details for Guggenheim rating of Adaptimmune Therapeutics (NASDAQ:ADAP) on 3/26/2025 |
ZURA Zura Bio | $1.23
+7.0% | 3/26/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $15.00 -> $15.00 | Medium | View details for Guggenheim rating of Zura Bio (NASDAQ:ZURA) on 3/26/2025 |
MTZ MasTec | $115.97
-1.2% | 3/25/2025 | Reiterated by | Guggenheim | Analyst J. Osha | Buy -> Buy | $195.00 -> $195.00 | Low | View details for Guggenheim rating of MasTec (NYSE:MTZ) on 3/25/2025 |
FOXA FOX | $47.97
-0.6% | 3/25/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $60.00 -> $60.00 | Medium | View details for Guggenheim rating of FOX (NASDAQ:FOXA) on 3/25/2025 |
LRMR Larimar Therapeutics | $1.91
+3.5% | 3/25/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $26.00 -> $26.00 | Medium | View details for Guggenheim rating of Larimar Therapeutics (NASDAQ:LRMR) on 3/25/2025 |
VERV Verve Therapeutics | $4.59
+1.8% | 3/25/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | High | View details for Guggenheim rating of Verve Therapeutics (NASDAQ:VERV) on 3/25/2025 |
ASMB Assembly Biosciences | $10.03
+0.2% | 3/25/2025 | Initiated by | Guggenheim | Analyst Vamil Divan | Buy | $31.00 | Low | View details for Guggenheim rating of Assembly Biosciences (NASDAQ:ASMB) on 3/25/2025 |
DRI Darden Restaurants | $200.03
+1.1% | 3/24/2025 | Target Raised by | Guggenheim | Analyst Greg Francfort | Buy -> Buy | $205.00 -> $220.00 | High | View details for Guggenheim rating of Darden Restaurants (NYSE:DRI) on 3/24/2025 |
VSTM Verastem | $5.74
+15.7% | 3/24/2025 | Target Raised by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | $13.00 -> $14.00 | Medium | View details for Guggenheim rating of Verastem (NASDAQ:VSTM) on 3/24/2025 |
VALN Valneva | $6.79
+3.3% | 3/24/2025 | Target Lowered by | Guggenheim | Analyst Dana Flanders | Buy -> Buy | $17.00 -> $15.00 | High | View details for Guggenheim rating of Valneva (NASDAQ:VALN) on 3/24/2025 |
PINS Pinterest | $25.17
-1.1% | 3/24/2025 | Upgraded by | Guggenheim | Analyst Michael Morris | Neutral -> Buy | $39.00 -> $40.00 | Low | View details for Guggenheim rating of Pinterest (NYSE:PINS) on 3/24/2025 |
ACN Accenture | $282.28
-1.0% | 3/21/2025 | Target Lowered by | Guggenheim | Analyst Jonathan Lee | Buy -> Buy | $400.00 -> $395.00 | High | View details for Guggenheim rating of Accenture (NYSE:ACN) on 3/21/2025 |
DTE DTE Energy | $133.33
+1.0% | 3/21/2025 | Target Raised by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | $139.00 -> $147.00 | Medium | View details for Guggenheim rating of DTE Energy (NYSE:DTE) on 3/21/2025 |
IPSC Century Therapeutics | $0.54
+8.7% | 3/21/2025 | Target Lowered by | Guggenheim | Analyst Kelsey Goodwin | Buy -> Buy | $12.00 -> $5.00 | Medium | View details for Guggenheim rating of Century Therapeutics (NASDAQ:IPSC) on 3/21/2025 |
FIVE Five Below | $67.41
+7.5% | 3/21/2025 | Target Lowered by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $140.00 -> $125.00 | Medium | View details for Guggenheim rating of Five Below (NASDAQ:FIVE) on 3/21/2025 |
ACET Adicet Bio | $0.53
-8.0% | 3/21/2025 | Reiterated by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | $7.00 -> $7.00 | Low | View details for Guggenheim rating of Adicet Bio (NASDAQ:ACET) on 3/21/2025 |
NEE NextEra Energy | $66.29
+1.0% | 3/20/2025 | Reiterated by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $89.00 -> $89.00 | Low | View details for Guggenheim rating of NextEra Energy (NYSE:NEE) on 3/20/2025 |
IMVT Immunovant | $15.15
+2.1% | 3/20/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | | High | View details for Guggenheim rating of Immunovant (NASDAQ:IMVT) on 3/20/2025 |
RDDT Reddit | $96.04
+0.7% | 3/20/2025 | Target Lowered by | Guggenheim | Analyst M. Morris | Buy -> Buy | $210.00 -> $170.00 | Medium | View details for Guggenheim rating of Reddit (NYSE:RDDT) on 3/20/2025 |
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now (Ad) Did Elon Musk just set the stage for the next AI stock explosion?
One 30-year Wall Street veteran thinks so.
Musk has been quietly creating one of the most ambitious AI ventures in history. For all the details - including the name and ticker of our #1 AI stock to buy right now - click here |
IMNM Immunome | $7.91
+10.3% | 3/20/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $35.00 -> $25.00 | Medium | View details for Guggenheim rating of Immunome (NASDAQ:IMNM) on 3/20/2025 |
ABSI Absci | $3.09
+1.3% | 3/20/2025 | Reiterated by | Guggenheim | Analyst V. Divan | Buy -> Buy | $10.00 -> $10.00 | Medium | View details for Guggenheim rating of Absci (NASDAQ:ABSI) on 3/20/2025 |
EOSE Eos Energy Enterprises | $4.75
-3.0% | 3/18/2025 | Reiterated by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $7.00 -> $7.00 | Low | View details for Guggenheim rating of Eos Energy Enterprises (NASDAQ:EOSE) on 3/18/2025 |
MRUS Merus | $43.06
+2.7% | 3/18/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $109.00 -> $109.00 | Low | View details for Guggenheim rating of Merus (NASDAQ:MRUS) on 3/18/2025 |
PFE Pfizer | $22.13
+0.4% | 3/18/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | | Low | View details for Guggenheim rating of Pfizer (NYSE:PFE) on 3/18/2025 |
ZBIO Zenas Biopharma | $8.92
+7.1% | 3/12/2025 | Reiterated by | Guggenheim | Analyst Y. Suneja | Buy -> Buy | $45.00 -> $45.00 | Medium | View details for Guggenheim rating of Zenas Biopharma (NASDAQ:ZBIO) on 3/12/2025 |
RBRK Rubrik | $61.48
-1.3% | 3/18/2025 | Target Raised by | Guggenheim | Analyst John Difucci | Buy -> Buy | $76.00 -> $80.00 | Low | View details for Guggenheim rating of Rubrik (NYSE:RBRK) on 3/18/2025 |
GENI Genius Sports | $10.35
+1.2% | 3/18/2025 | Initiated by | Guggenheim | Analyst Curry Baker | Buy | $12.00 | High | View details for Guggenheim rating of Genius Sports (NYSE:GENI) on 3/18/2025 |
INCY Incyte | $58.21
+0.8% | 3/18/2025 | Downgraded by | Guggenheim | Analyst Michael Schmidt | Buy -> Neutral | $92.00 -> $92.00 | High | View details for Guggenheim rating of Incyte (NASDAQ:INCY) on 3/18/2025 |
GNRC Generac | $111.59
+0.8% | 3/17/2025 | Upgraded by | Guggenheim | Analyst J. Osha | Sell -> Neutral | | Low | View details for Guggenheim rating of Generac (NYSE:GNRC) on 3/17/2025 |
ZVRA Zevra Therapeutics | $7.15
+1.4% | 3/13/2025 | Target Raised by | Guggenheim | Analyst E. Hickman | Buy -> Buy | $20.00 -> $22.00 | Medium | View details for Guggenheim rating of Zevra Therapeutics (NASDAQ:ZVRA) on 3/13/2025 |
ARVN Arvinas | $8.60
+12.4% | 3/13/2025 | Target Lowered by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $57.00 -> $32.00 | Low | View details for Guggenheim rating of Arvinas (NASDAQ:ARVN) on 3/13/2025 |
GHRS GH Research | $9.10
+4.6% | 3/13/2025 | Initiated by | Guggenheim | Analyst Eddie Hickman | Buy | $32.00 | Medium | View details for Guggenheim rating of GH Research (NASDAQ:GHRS) on 3/13/2025 |
CYBN Cybin | $7.35
-1.3% | 3/13/2025 | Initiated by | Guggenheim | Analyst Eddie Hickman | Buy | $35.00 | High | View details for Guggenheim rating of Cybin (NYSE:CYBN) on 3/13/2025 |
LEGN Legend Biotech | $32.80
-2.0% | 3/12/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Neutral -> Neutral | | Medium | View details for Guggenheim rating of Legend Biotech (NASDAQ:LEGN) on 3/12/2025 |
DKS DICK'S Sporting Goods | $185.33
+2.6% | 3/12/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Neutral -> Neutral | | Low | View details for Guggenheim rating of DICK’S Sporting Goods (NYSE:DKS) on 3/12/2025 |
DNTH Dianthus Therapeutics | $19.50
+2.7% | 3/12/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $84.00 -> $84.00 | High | View details for Guggenheim rating of Dianthus Therapeutics (NASDAQ:DNTH) on 3/12/2025 |
PCVX Vaxcyte | $30.65
+5.3% | 3/12/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | $160.00 -> $160.00 | Low | View details for Guggenheim rating of Vaxcyte (NASDAQ:PCVX) on 3/12/2025 |
PFE Pfizer | $22.13
+0.4% | 3/12/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | | Low | View details for Guggenheim rating of Pfizer (NYSE:PFE) on 3/12/2025 |
TSLA Tesla | $241.17
-0.2% | 3/12/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Sell -> Sell | $175.00 -> $170.00 | Low | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 3/12/2025 |
GNTX Gentex | $21.56
+2.3% | 3/5/2025 | Target Set by | Guggenheim | - | | $30.00 | Low | View details for Guggenheim rating of Gentex (NASDAQ:GNTX) on 3/5/2025 |
ANAB AnaptysBio | $20.55
+7.8% | 3/3/2025 | Reiterated by | Guggenheim | - | Buy -> Buy | | High | View details for Guggenheim rating of AnaptysBio (NASDAQ:ANAB) on 3/3/2025 |
GTN Gray Television | $3.35
+0.1% | 3/10/2025 | Target Lowered by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $8.00 -> $7.00 | Medium | View details for Guggenheim rating of Gray Television (NYSE:GTN) on 3/10/2025 |
ORLY O'Reilly Automotive | $1,390.90
+1.9% | 3/10/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $1,475.00 -> $1,475.00 | Low | View details for Guggenheim rating of O’Reilly Automotive (NASDAQ:ORLY) on 3/10/2025 |
W Wayfair | $26.58
+5.7% | 3/10/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $60.00 -> $60.00 | Low | View details for Guggenheim rating of Wayfair (NYSE:W) on 3/10/2025 |
JNJ Johnson & Johnson | $157.42
+2.3% | 3/10/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Neutral -> Neutral | | Medium | View details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 3/10/2025 |
IMVT Immunovant | $15.15
+2.1% | 3/10/2025 | Reiterated by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | | Low | View details for Guggenheim rating of Immunovant (NASDAQ:IMVT) on 3/10/2025 |
NAUT Nautilus Biotechnology | $0.76
+4.8% | 2/28/2025 | Target Set by | Guggenheim | - | | $2.50 | High | View details for Guggenheim rating of Nautilus Biotechnology (NASDAQ:NAUT) on 2/28/2025 |
ONC Beigene | $230.98
+1.2% | 2/28/2025 | Reiterated by | Guggenheim | - | Buy -> Buy | | Low | View details for Guggenheim rating of Beigene (NASDAQ:ONC) on 2/28/2025 |
FWONA Formula One Group | $75.13
+3.8% | 3/3/2025 | Reiterated by | Guggenheim | - | Buy -> Buy | | Low | View details for Guggenheim rating of Formula One Group (NASDAQ:FWONA) on 3/3/2025 |
ARGX argenx | $596.20
+1.5% | 3/10/2025 | Target Raised by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $775.00 -> $1,100.00 | Medium | View details for Guggenheim rating of argenx (NASDAQ:ARGX) on 3/10/2025 |
IHRT iHeartMedia | $0.98
-3.9% | 3/10/2025 | Target Lowered by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $5.00 -> $4.50 | Medium | View details for Guggenheim rating of iHeartMedia (NASDAQ:IHRT) on 3/10/2025 |
SBGI Sinclair | $14.14
+1.1% | 3/10/2025 | Target Lowered by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $19.00 -> $17.00 | High | View details for Guggenheim rating of Sinclair (NASDAQ:SBGI) on 3/10/2025 |
VG Venture Global | $8.62
-2.9% | 3/10/2025 | Target Lowered by | Guggenheim | Analyst S. Pourreza | Buy -> Buy | $27.00 -> $20.00 | High | View details for Guggenheim rating of Venture Global (NYSE:VG) on 3/10/2025 |
BWA BorgWarner | $26.42
+1.5% | 3/5/2025 | Target Set by | Guggenheim | - | | $38.00 | N/A | View details for Guggenheim rating of BorgWarner (NYSE:BWA) on 3/5/2025 |
PHAT Phathom Pharmaceuticals | $4.03
-4.5% | 3/7/2025 | Target Set by | Guggenheim | - | | $18.00 | N/A | View details for Guggenheim rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 3/7/2025 |
AVBP ArriVent BioPharma | $18.14
+1.3% | 3/10/2025 | Initiated by | Guggenheim | Analyst Michael Schmidt | Buy | $45.00 | Medium | View details for Guggenheim rating of ArriVent BioPharma (NASDAQ:AVBP) on 3/10/2025 |
NMRA Neumora Therapeutics | $0.65
+2.7% | 3/7/2025 | Downgraded by | Guggenheim | Analyst Yatin Suneja | Buy -> Neutral | | High | View details for Guggenheim rating of Neumora Therapeutics (NASDAQ:NMRA) on 3/7/2025 |
ARRY Array Technologies | $4.32
+5.8% | 3/7/2025 | Upgraded by | Guggenheim | Analyst J. Osha | Neutral -> Buy | $10.00 | N/A | View details for Guggenheim rating of Array Technologies (NASDAQ:ARRY) on 3/7/2025 |
NOVA Sunnova Energy International | $0.17
-6.5% | 3/5/2025 | Upgraded by | Guggenheim | Analyst J. Osha | Hold -> Strong-Buy | | Medium | View details for Guggenheim rating of Sunnova Energy International (NYSE:NOVA) on 3/5/2025 |
ANIP ANI Pharmaceuticals | $69.21
+0.0% | 3/5/2025 | Target Raised by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $84.00 -> $86.00 | Medium | View details for Guggenheim rating of ANI Pharmaceuticals (NASDAQ:ANIP) on 3/5/2025 |
AZO AutoZone | $3,601.29
+1.0% | 3/5/2025 | Target Raised by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $3,750.00 -> $3,850.00 | Medium | View details for Guggenheim rating of AutoZone (NYSE:AZO) on 3/5/2025 |
DUK Duke Energy | $121.65
+1.1% | 3/5/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $132.00 -> $135.00 | Low | View details for Guggenheim rating of Duke Energy (NYSE:DUK) on 3/5/2025 |
FUN Cedar Fair | $33.36
+4.8% | 3/5/2025 | Target Lowered by | Guggenheim | Analyst C. Baker | Buy -> Buy | $55.00 -> $50.00 | Low | View details for Guggenheim rating of Cedar Fair (NYSE:FUN) on 3/5/2025 |
ORCL Oracle | $128.56
-0.9% | 3/5/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $220.00 -> $220.00 | Medium | View details for Guggenheim rating of Oracle (NYSE:ORCL) on 3/5/2025 |
CRWD CrowdStrike | $375.62
-1.1% | 3/5/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | High | View details for Guggenheim rating of CrowdStrike (NASDAQ:CRWD) on 3/5/2025 |
BBY Best Buy | $61.97
+3.9% | 3/5/2025 | Target Lowered by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $105.00 -> $90.00 | Medium | View details for Guggenheim rating of Best Buy (NYSE:BBY) on 3/5/2025 |
GEV GE Vernova | $322.81
-1.6% | 3/5/2025 | Upgraded by | Guggenheim | Analyst J. Osha | Neutral -> Buy | $380.00 | Medium | View details for Guggenheim rating of GE Vernova (NYSE:GEV) on 3/5/2025 |
SION Sionna Therapeutics | $11.07
+10.7% | 3/4/2025 | Initiated by | Guggenheim | Analyst Y. Suneja | Buy | $45.00 | Low | View details for Guggenheim rating of Sionna Therapeutics (NASDAQ:SION) on 3/4/2025 |
FE FirstEnergy | $41.87
+2.6% | 2/28/2025 | Target Lowered by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $52.00 -> $45.00 | Medium | View details for Guggenheim rating of FirstEnergy (NYSE:FE) on 2/28/2025 |
Claim Your FREE Protection Guide (Ad) In the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code...
And since then, "in the know" patriots have quietly used this same "Trump loophole" to shield their life savings from the economic chaos.
But with Trump now forcefully bringing back millions of manufacturing jobs from Mexico, China, and the entire BRICS anti-dollar coalition... Click Here to Claim Your FREE Trump 100-Day Strategy Guide Now → |
ESTC Elastic | $77.79
-1.3% | 2/28/2025 | Target Raised by | Guggenheim | Analyst H. Ma | Buy -> Buy | $130.00 -> $136.00 | High | View details for Guggenheim rating of Elastic (NYSE:ESTC) on 2/28/2025 |
NXST Nexstar Media Group | $147.50
+0.2% | 2/28/2025 | Target Raised by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $210.00 -> $220.00 | Low | View details for Guggenheim rating of Nexstar Media Group (NASDAQ:NXST) on 2/28/2025 |
LTH Life Time Group | $31.30
+0.2% | 2/28/2025 | Target Raised by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $32.00 -> $36.00 | High | View details for Guggenheim rating of Life Time Group (NYSE:LTH) on 2/28/2025 |
CRM Salesforce | $246.93
-1.2% | 2/27/2025 | Reiterated by | Guggenheim | Analyst J. Difucci | Sell -> Sell | $247.00 -> $247.00 | High | View details for Guggenheim rating of Salesforce (NYSE:CRM) on 2/27/2025 |
PARA Paramount Global | $10.94
+2.1% | 2/27/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $14.00 -> $14.00 | Low | View details for Guggenheim rating of Paramount Global (NASDAQ:PARA) on 2/27/2025 |
SNOW Snowflake | $143.34
-1.9% | 2/27/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | High | View details for Guggenheim rating of Snowflake (NYSE:SNOW) on 2/27/2025 |
JACK Jack in the Box | $23.22
+1.6% | 2/27/2025 | Reiterated by | Guggenheim | Analyst Gregory Francfort | Buy -> Buy | $55.00 -> $55.00 | Medium | View details for Guggenheim rating of Jack in the Box (NASDAQ:JACK) on 2/27/2025 |
BEAM Beam Therapeutics | $17.00
+2.3% | 2/27/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | $78.00 -> $78.00 | High | View details for Guggenheim rating of Beam Therapeutics (NASDAQ:BEAM) on 2/27/2025 |
PLNT Planet Fitness | $93.91
-0.6% | 2/27/2025 | Reiterated by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $105.00 -> $105.00 | Low | View details for Guggenheim rating of Planet Fitness (NYSE:PLNT) on 2/27/2025 |
FSLR First Solar | $127.98
+2.9% | 2/27/2025 | Target Lowered by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $335.00 -> $304.00 | High | View details for Guggenheim rating of First Solar (NASDAQ:FSLR) on 2/27/2025 |
ITRI Itron | $103.26
+1.6% | 2/27/2025 | Target Lowered by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $135.00 -> $133.00 | Low | View details for Guggenheim rating of Itron (NASDAQ:ITRI) on 2/27/2025 |
TKO TKO Group | $149.41
+1.0% | 2/27/2025 | Target Raised by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $170.00 -> $175.00 | High | View details for Guggenheim rating of TKO Group (NYSE:TKO) on 2/27/2025 |
TXRH Texas Roadhouse | $161.89
+0.9% | 2/27/2025 | Target Lowered by | Guggenheim | Analyst Gregory Francfort | Buy -> Buy | $205.00 -> $200.00 | Low | View details for Guggenheim rating of Texas Roadhouse (NASDAQ:TXRH) on 2/27/2025 |
VERA Vera Therapeutics | $21.29
+0.2% | 2/27/2025 | Target Raised by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $59.00 -> $61.00 | Low | View details for Guggenheim rating of Vera Therapeutics (NASDAQ:VERA) on 2/27/2025 |
NRG NRG Energy | $97.84
-0.3% | 2/27/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $134.00 -> $145.00 | High | View details for Guggenheim rating of NRG Energy (NYSE:NRG) on 2/27/2025 |
PRKS United Parks & Resorts | $44.28
+3.1% | 2/27/2025 | Target Raised by | Guggenheim | Analyst Curry Baker | Buy -> Buy | $70.00 -> $72.00 | High | View details for Guggenheim rating of United Parks & Resorts (NYSE:PRKS) on 2/27/2025 |
BASE Couchbase | $14.89
+1.4% | 2/26/2025 | Target Lowered by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $30.00 -> $26.00 | High | View details for Guggenheim rating of Couchbase (NASDAQ:BASE) on 2/26/2025 |
SRE Sempra | $71.14
+1.1% | 2/26/2025 | Target Lowered by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $95.00 -> $87.00 | Low | View details for Guggenheim rating of Sempra (NYSE:SRE) on 2/26/2025 |
HD Home Depot | $354.85
+2.6% | 2/26/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $450.00 -> $450.00 | Medium | View details for Guggenheim rating of Home Depot (NYSE:HD) on 2/26/2025 |
WDAY Workday | $221.02
-2.9% | 2/26/2025 | Reiterated by | Guggenheim | Analyst J. Difucci | Neutral -> Neutral | | Medium | View details for Guggenheim rating of Workday (NASDAQ:WDAY) on 2/26/2025 |
PCVX Vaxcyte | $30.65
+5.3% | 2/26/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | $160.00 -> $160.00 | High | View details for Guggenheim rating of Vaxcyte (NASDAQ:PCVX) on 2/26/2025 |
PEG Public Service Enterprise Group | $83.33
+0.4% | 2/26/2025 | Reiterated by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $98.00 -> $98.00 | Medium | View details for Guggenheim rating of Public Service Enterprise Group (NYSE:PEG) on 2/26/2025 |
RBRK Rubrik | $61.48
-1.3% | 2/26/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $76.00 -> $76.00 | Low | View details for Guggenheim rating of Rubrik (NYSE:RBRK) on 2/26/2025 |
ORIC ORIC Pharmaceuticals | $4.77
+1.7% | 2/26/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | | High | View details for Guggenheim rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 2/26/2025 |
PNW Pinnacle West Capital | $94.48
+1.1% | 2/26/2025 | Reiterated by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | $100.00 -> $100.00 | Medium | View details for Guggenheim rating of Pinnacle West Capital (NYSE:PNW) on 2/26/2025 |
PMN ProMIS Neurosciences | $0.64
+3.4% | 2/26/2025 | Reiterated by | Guggenheim | Analyst Eddie Hickman | Buy -> Buy | | High | View details for Guggenheim rating of ProMIS Neurosciences (NASDAQ:PMN) on 2/26/2025 |
SRAD Sportradar Group | $23.96
+0.4% | 2/26/2025 | Initiated by | Guggenheim | Analyst Curry Baker | Buy | $27.00 | Low | View details for Guggenheim rating of Sportradar Group (NASDAQ:SRAD) on 2/26/2025 |
MAZE Maze Therapeutics | $8.41
+2.8% | 2/25/2025 | Initiated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy | $19.00 | High | View details for Guggenheim rating of Maze Therapeutics (NASDAQ:MAZE) on 2/25/2025 |
TEM Tempus AI | $40.42
-1.1% | 2/25/2025 | Reiterated by | Guggenheim | Analyst S. Nambi | Buy -> Buy | | Low | View details for Guggenheim rating of Tempus AI (NASDAQ:TEM) on 2/25/2025 |
VCYT Veracyte | $31.14
-1.2% | 2/25/2025 | Reiterated by | Guggenheim | Analyst S. Nambi | Buy -> Buy | $45.00 -> $45.00 | High | View details for Guggenheim rating of Veracyte (NASDAQ:VCYT) on 2/25/2025 |
CYBR CyberArk Software | $325.84
-1.6% | 2/25/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Buy -> Buy | $455.00 -> $455.00 | High | View details for Guggenheim rating of CyberArk Software (NASDAQ:CYBR) on 2/25/2025 |
TSLA Tesla | $241.17
-0.2% | 2/25/2025 | Reiterated by | Guggenheim | Analyst Ronald Jewsikow | Sell -> Sell | | High | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 2/25/2025 |
INSM Insmed | $72.53
+3.3% | 2/25/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $101.00 -> $101.00 | Medium | View details for Guggenheim rating of Insmed (NASDAQ:INSM) on 2/25/2025 |
MTSR Metsera | $19.57
+11.5% | 2/25/2025 | Initiated by | Guggenheim | Analyst Seamus Fernandez | Buy | $56.00 | High | View details for Guggenheim rating of Metsera (NASDAQ:MTSR) on 2/25/2025 |
LNT Alliant Energy | $60.80
+0.6% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Shahriar Pourreza | Neutral -> Neutral | $57.00 -> $57.00 | Medium | View details for Guggenheim rating of Alliant Energy (NASDAQ:LNT) on 2/24/2025 |
GH Guardant Health | $44.97
-0.5% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $56.00 -> $56.00 | Medium | View details for Guggenheim rating of Guardant Health (NASDAQ:GH) on 2/24/2025 |
SPOT Spotify Technology | $574.85
+2.1% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $675.00 -> $675.00 | Low | View details for Guggenheim rating of Spotify Technology (NYSE:SPOT) on 2/24/2025 |
MLYS Mineralys Therapeutics | $13.35
-1.1% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | Low | View details for Guggenheim rating of Mineralys Therapeutics (NASDAQ:MLYS) on 2/24/2025 |
WMT Walmart | $93.17
+2.2% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $100.00 -> $100.00 | Low | View details for Guggenheim rating of Walmart (NYSE:WMT) on 2/24/2025 |
BRKR Bruker | $36.28
-3.9% | 2/24/2025 | Reiterated by | Guggenheim | Analyst S. Nambi | Buy -> Buy | | Low | View details for Guggenheim rating of Bruker (NASDAQ:BRKR) on 2/24/2025 |
TARS Tarsus Pharmaceuticals | $49.25
-0.3% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Eddie Hickman | Buy -> Buy | $75.00 -> $78.00 | High | View details for Guggenheim rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 2/24/2025 |
ARQT Arcutis Biotherapeutics | $13.01
+0.4% | 2/24/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | High | View details for Guggenheim rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 2/24/2025 |
RIVN Rivian Automotive | $11.60
+1.0% | 2/24/2025 | Target Lowered by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | $18.00 -> $16.00 | Low | View details for Guggenheim rating of Rivian Automotive (NASDAQ:RIVN) on 2/24/2025 |
WING Wingstop | $218.84
+0.5% | 2/24/2025 | Upgraded by | Guggenheim | Analyst Gregory Francfort | Neutral -> Buy | $280.00 | Low | View details for Guggenheim rating of Wingstop (NASDAQ:WING) on 2/24/2025 |
CMPX Compass Therapeutics | $1.75
+2.9% | 2/24/2025 | Initiated by | Guggenheim | Analyst Michael Schmidt | Buy | $12.00 | Medium | View details for Guggenheim rating of Compass Therapeutics (NASDAQ:CMPX) on 2/24/2025 |
CHWY Chewy | $35.18
+1.2% | 2/4/2025 | Target Set by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $42.00 | Medium | View details for Guggenheim rating of Chewy (NYSE:CHWY) on 2/4/2025 |
ZVRA Zevra Therapeutics | $7.15
+1.4% | 2/4/2025 | Target Set by | Guggenheim | Analyst E. Hickman | Buy -> Buy | $21.00 | High | View details for Guggenheim rating of Zevra Therapeutics (NASDAQ:ZVRA) on 2/4/2025 |
VG Venture Global | $8.62
-2.9% | 2/18/2025 | Initiated by | Guggenheim | Analyst S. Pourreza | Buy | $27.00 | High | View details for Guggenheim rating of Venture Global (NYSE:VG) on 2/18/2025 |
PCG PG&E | $17.23
+0.3% | 2/18/2025 | Downgraded by | Guggenheim | Analyst S. Pourreza | Buy -> Neutral | | Low | View details for Guggenheim rating of PG&E (NYSE:PCG) on 2/18/2025 |
NKE NIKE | $55.73
+4.1% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $110.00 -> $110.00 | Low | View details for Guggenheim rating of NIKE (NYSE:NKE) on 2/12/2025 |
Claim Your FREE Protection Guide (Ad) In the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code...
And since then, "in the know" patriots have quietly used this same "Trump loophole" to shield their life savings from the economic chaos.
But with Trump now forcefully bringing back millions of manufacturing jobs from Mexico, China, and the entire BRICS anti-dollar coalition... Click Here to Claim Your FREE Trump 100-Day Strategy Guide Now → |
CPRI Capri | $13.74
+3.5% | 2/12/2025 | Reiterated by | Guggenheim | Analyst R. Drbul | Buy -> Buy | $30.00 -> $30.00 | Medium | View details for Guggenheim rating of Capri (NYSE:CPRI) on 2/12/2025 |
MRUS Merus | $43.06
+2.7% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | | Low | View details for Guggenheim rating of Merus (NASDAQ:MRUS) on 2/12/2025 |
UTL Unitil | $58.62
+1.3% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Shahriar Pourreza | Neutral -> Neutral | $55.00 -> $55.00 | High | View details for Guggenheim rating of Unitil (NYSE:UTL) on 2/12/2025 |
AN AutoNation | $166.03
+2.4% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Ronald Jewsikow | Buy -> Buy | | Low | View details for Guggenheim rating of AutoNation (NYSE:AN) on 2/12/2025 |
MRK Merck & Co., Inc. | $77.93
+1.9% | 2/12/2025 | Target Lowered by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $122.00 -> $115.00 | Low | View details for Guggenheim rating of Merck & Co., Inc. (NYSE:MRK) on 2/12/2025 |
TDC Teradata | $20.38
+0.5% | 2/12/2025 | Target Lowered by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $42.00 -> $37.00 | High | View details for Guggenheim rating of Teradata (NYSE:TDC) on 2/12/2025 |
CFLT Confluent | $21.15
-1.7% | 2/12/2025 | Target Raised by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $35.00 -> $38.00 | High | View details for Guggenheim rating of Confluent (NASDAQ:CFLT) on 2/12/2025 |
OS Onestream | $19.66
+1.3% | 2/12/2025 | Reiterated by | Guggenheim | Analyst J. Difucci | Buy -> Buy | $35.00 -> $35.00 | High | View details for Guggenheim rating of Onestream (NASDAQ:OS) on 2/12/2025 |
ARVN Arvinas | $8.60
+12.4% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $57.00 -> $57.00 | High | View details for Guggenheim rating of Arvinas (NASDAQ:ARVN) on 2/12/2025 |
EXEL Exelixis | $36.19
+0.1% | 2/12/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | $42.00 -> $42.00 | High | View details for Guggenheim rating of Exelixis (NASDAQ:EXEL) on 2/12/2025 |
FLNC Fluence Energy | $3.69
+1.4% | 2/11/2025 | Downgraded by | Guggenheim | Analyst J. Osha | Buy -> Sell | $26.00 -> $6.00 | High | View details for Guggenheim rating of Fluence Energy (NASDAQ:FLNC) on 2/11/2025 |
SNAP Snap | $7.86
+1.6% | 2/11/2025 | Downgraded by | Guggenheim | Analyst M. Morris | Buy -> Neutral | | Medium | View details for Guggenheim rating of Snap (NYSE:SNAP) on 2/11/2025 |
RZLT Rezolute | $2.75
+4.2% | 2/10/2025 | Reiterated by | Guggenheim | Analyst D. Chattopadhyay | Buy -> Buy | | Low | View details for Guggenheim rating of Rezolute (NASDAQ:RZLT) on 2/10/2025 |
TARS Tarsus Pharmaceuticals | $49.25
-0.3% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Eddie Hickman | Buy -> Buy | | Medium | View details for Guggenheim rating of Tarsus Pharmaceuticals (NASDAQ:TARS) on 2/10/2025 |
APGE Apogee Therapeutics | $33.11
+3.3% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | Low | View details for Guggenheim rating of Apogee Therapeutics (NASDAQ:APGE) on 2/10/2025 |
ARQT Arcutis Biotherapeutics | $13.01
+0.4% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Seamus Fernandez | Buy -> Buy | | High | View details for Guggenheim rating of Arcutis Biotherapeutics (NASDAQ:ARQT) on 2/10/2025 |
ORIC ORIC Pharmaceuticals | $4.77
+1.7% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Michael Schmidt | Buy -> Buy | | High | View details for Guggenheim rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 2/10/2025 |
ES Eversource Energy | $57.38
-1.2% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Shahriar Pourreza | Buy -> Buy | | High | View details for Guggenheim rating of Eversource Energy (NYSE:ES) on 2/10/2025 |
CNTA Centessa Pharmaceuticals | $12.30
+4.0% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Debjit Chattopadhyay | Buy -> Buy | | High | View details for Guggenheim rating of Centessa Pharmaceuticals (NASDAQ:CNTA) on 2/10/2025 |
IMVT Immunovant | $15.15
+2.1% | 2/10/2025 | Target Lowered by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $46.00 -> $44.00 | High | View details for Guggenheim rating of Immunovant (NASDAQ:IMVT) on 2/10/2025 |
NBIX Neurocrine Biosciences | $101.38
+1.3% | 2/10/2025 | Target Lowered by | Guggenheim | Analyst Yatin Suneja | Buy -> Buy | $165.00 -> $163.00 | High | View details for Guggenheim rating of Neurocrine Biosciences (NASDAQ:NBIX) on 2/10/2025 |
PFE Pfizer | $22.13
+0.4% | 2/10/2025 | Reiterated by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $33.00 -> $33.00 | Low | View details for Guggenheim rating of Pfizer (NYSE:PFE) on 2/10/2025 |
RL Ralph Lauren | $206.51
+2.2% | 2/7/2025 | Target Raised by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $285.00 -> $310.00 | Low | View details for Guggenheim rating of Ralph Lauren (NYSE:RL) on 2/7/2025 |
INSM Insmed | $72.53
+3.3% | 2/7/2025 | Target Raised by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $95.00 -> $101.00 | Low | View details for Guggenheim rating of Insmed (NASDAQ:INSM) on 2/7/2025 |
KR Kroger | $71.30
+3.3% | 2/7/2025 | Target Raised by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $68.00 -> $71.00 | Low | View details for Guggenheim rating of Kroger (NYSE:KR) on 2/7/2025 |
TPR Tapestry | $63.53
+1.0% | 2/7/2025 | Target Raised by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $70.00 -> $90.00 | Low | View details for Guggenheim rating of Tapestry (NYSE:TPR) on 2/7/2025 |
FTNT Fortinet | $96.13
+0.1% | 2/7/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | High | View details for Guggenheim rating of Fortinet (NASDAQ:FTNT) on 2/7/2025 |
LESL Leslie's | $0.58
+5.8% | 2/7/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Neutral -> Neutral | | High | View details for Guggenheim rating of Leslie’s (NASDAQ:LESL) on 2/7/2025 |
WMG Warner Music Group | $29.12
+1.9% | 2/7/2025 | Reiterated by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $40.00 -> $40.00 | Medium | View details for Guggenheim rating of Warner Music Group (NASDAQ:WMG) on 2/7/2025 |
UAA Under Armour | $5.84
+4.9% | 2/7/2025 | Reiterated by | Guggenheim | Analyst Robert Drbul | Neutral -> Neutral | | Medium | View details for Guggenheim rating of Under Armour (NYSE:UAA) on 2/7/2025 |
CMS CMS Energy | $72.81
+0.9% | 2/7/2025 | Reiterated by | Guggenheim | Analyst S. Pourreza | Neutral -> Neutral | $69.00 -> $69.00 | Medium | View details for Guggenheim rating of CMS Energy (NYSE:CMS) on 2/7/2025 |
ORLY O'Reilly Automotive | $1,390.90
+1.9% | 2/7/2025 | Target Raised by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $1,400.00 -> $1,475.00 | Medium | View details for Guggenheim rating of O’Reilly Automotive (NASDAQ:ORLY) on 2/7/2025 |
NET Cloudflare | $107.81
-1.6% | 2/7/2025 | Target Raised by | Guggenheim | Analyst John Difucci | Sell -> Sell | $57.00 -> $68.00 | High | View details for Guggenheim rating of Cloudflare (NYSE:NET) on 2/7/2025 |
PINS Pinterest | $25.17
-1.1% | 2/7/2025 | Target Raised by | Guggenheim | Analyst Michael Morris | Neutral -> Neutral | $33.00 -> $39.00 | High | View details for Guggenheim rating of Pinterest (NYSE:PINS) on 2/7/2025 |
ILMN Illumina | $71.21
-3.2% | 2/7/2025 | Target Lowered by | Guggenheim | Analyst Subbu Nambi | Buy -> Buy | $170.00 -> $150.00 | High | View details for Guggenheim rating of Illumina (NASDAQ:ILMN) on 2/7/2025 |
FOXA FOX | $47.97
-0.6% | 2/5/2025 | Target Raised by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $55.00 -> $60.00 | Medium | View details for Guggenheim rating of FOX (NASDAQ:FOXA) on 2/5/2025 |
SPOT Spotify Technology | $574.85
+2.1% | 2/5/2025 | Target Raised by | Guggenheim | Analyst Michael Morris | Buy -> Buy | $520.00 -> $675.00 | Medium | View details for Guggenheim rating of Spotify Technology (NYSE:SPOT) on 2/5/2025 |
NJR New Jersey Resources | $49.67
-0.1% | 2/5/2025 | Target Raised by | Guggenheim | Analyst Shahriar Pourreza | Neutral -> Neutral | $53.00 -> $54.00 | Medium | View details for Guggenheim rating of New Jersey Resources (NYSE:NJR) on 2/5/2025 |
LEVI Levi Strauss & Co. | $14.62
+3.6% | 2/3/2025 | Target Raised by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $20.00 -> $22.00 | Low | View details for Guggenheim rating of Levi Strauss & Co. (NYSE:LEVI) on 2/3/2025 |
JNJ Johnson & Johnson | $157.42
+2.3% | 2/3/2025 | Target Raised by | Guggenheim | Analyst Vamil Divan | Neutral -> Neutral | $162.00 -> $166.00 | Low | View details for Guggenheim rating of Johnson & Johnson (NYSE:JNJ) on 2/3/2025 |
ABBV AbbVie | $172.78
+0.6% | 2/3/2025 | Target Raised by | Guggenheim | Analyst Vamil Divan | Buy -> Buy | $212.00 -> $214.00 | High | View details for Guggenheim rating of AbbVie (NYSE:ABBV) on 2/3/2025 |
CROX Crocs | $90.72
+2.3% | 2/3/2025 | Target Lowered by | Guggenheim | Analyst R. Drbul | Buy -> Buy | $155.00 -> $150.00 | High | View details for Guggenheim rating of Crocs (NASDAQ:CROX) on 2/3/2025 |
CFLT Confluent | $21.15
-1.7% | 1/31/2025 | Target Raised by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $32.00 -> $35.00 | Medium | View details for Guggenheim rating of Confluent (NASDAQ:CFLT) on 1/31/2025 |
INFA Informatica | $17.53
+0.8% | 1/31/2025 | Reiterated by | Guggenheim | Analyst Howard Ma | Buy -> Buy | $37.00 -> $37.00 | Medium | View details for Guggenheim rating of Informatica (NYSE:INFA) on 1/31/2025 |
DECK Deckers Outdoor | $105.66
+2.6% | 1/31/2025 | Reiterated by | Guggenheim | Analyst R. Drbul | Neutral -> Neutral | | High | View details for Guggenheim rating of Deckers Outdoor (NYSE:DECK) on 1/31/2025 |
TSCO Tractor Supply | $50.11
+1.5% | 1/31/2025 | Reiterated by | Guggenheim | Analyst Steven Forbes | Buy -> Buy | $60.00 -> $60.00 | Medium | View details for Guggenheim rating of Tractor Supply (NASDAQ:TSCO) on 1/31/2025 |
CHKP Check Point Software Technologies | $214.96
+0.0% | 1/31/2025 | Reiterated by | Guggenheim | Analyst John Difucci | Neutral -> Neutral | | Low | View details for Guggenheim rating of Check Point Software Technologies (NASDAQ:CHKP) on 1/31/2025 |
DT Dynatrace | $43.08
-0.3% | 1/31/2025 | Reiterated by | Guggenheim | Analyst J. Difucci | Neutral -> Neutral | | Low | View details for Guggenheim rating of Dynatrace (NYSE:DT) on 1/31/2025 |
ENPH Enphase Energy | $52.54
+1.5% | 1/31/2025 | Upgraded by | Guggenheim | Analyst J. Osha | Sell -> Neutral | $62.00 -> $62.00 | Medium | View details for Guggenheim rating of Enphase Energy (NASDAQ:ENPH) on 1/31/2025 |
TSLA Tesla | $241.17
-0.2% | 1/29/2025 | Reiterated by | Guggenheim | Analyst Ronald Jewsikow | Sell -> Sell | $175.00 -> $175.00 | Low | View details for Guggenheim rating of Tesla (NASDAQ:TSLA) on 1/29/2025 |
NXT Nextracker | $40.30
+1.5% | 1/29/2025 | Target Raised by | Guggenheim | Analyst Joseph Osha | Buy -> Buy | $50.00 -> $62.00 | Low | View details for Guggenheim rating of Nextracker (NASDAQ:NXT) on 1/29/2025 |
SIRI Sirius XM | $20.31
+1.1% | 1/29/2025 | Target Lowered by | Guggenheim | Analyst C. Baker | Buy -> Buy | $30.00 -> $29.00 | Medium | View details for Guggenheim rating of Sirius XM (NASDAQ:SIRI) on 1/29/2025 |
RL Ralph Lauren | $206.51
+2.2% | 1/29/2025 | Target Raised by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $260.00 -> $285.00 | Low | View details for Guggenheim rating of Ralph Lauren (NYSE:RL) on 1/29/2025 |
XIFR XPLR Infrastructure | $8.84
+1.6% | 1/29/2025 | Target Lowered by | Guggenheim | Analyst S. Pourreza | Neutral -> Neutral | $17.00 -> $12.00 | Low | View details for Guggenheim rating of XPLR Infrastructure (NYSE:XIFR) on 1/29/2025 |
SYY Sysco | $71.71
+1.4% | 1/29/2025 | Reiterated by | Guggenheim | Analyst John Heinbockel | Buy -> Buy | $85.00 -> $85.00 | Low | View details for Guggenheim rating of Sysco (NYSE:SYY) on 1/29/2025 |
CVLT Commvault Systems | $149.74
-0.9% | 1/29/2025 | Reiterated by | Guggenheim | Analyst H. Ma | Neutral -> Neutral | | Low | View details for Guggenheim rating of Commvault Systems (NASDAQ:CVLT) on 1/29/2025 |
ELDN Eledon Pharmaceuticals | $2.99
-0.3% | 1/28/2025 | Initiated by | Guggenheim | Analyst V. Divan | Buy | $9.00 | High | View details for Guggenheim rating of Eledon Pharmaceuticals (NASDAQ:ELDN) on 1/28/2025 |
QSR Restaurant Brands International | C$87.56
+1.4% | 1/24/2025 | Upgraded by | Guggenheim | Analyst G. Francfort | Hold -> Strong-Buy | | N/A | View details for Guggenheim rating of Restaurant Brands International (TSE:QSR) on 1/24/2025 |
LEVI Levi Strauss & Co. | $14.62
+3.6% | 1/24/2025 | Reiterated by | Guggenheim | Analyst Robert Drbul | Buy -> Buy | $23.00 -> $23.00 | Low | View details for Guggenheim rating of Levi Strauss & Co. (NYSE:LEVI) on 1/24/2025 |
VSTM Verastem | $5.74
+15.7% | 1/24/2025 | Reiterated by | Guggenheim | Analyst M. Schmidt | Buy -> Buy | | High | View details for Guggenheim rating of Verastem (NASDAQ:VSTM) on 1/24/2025 |
